Sustaining GAVI-supported vaccine introductions in resource-poor countries. (Q53158191)

11 May 2018

title

Sustaining GAVI-supported vaccine introductions in resource-poor countries. (English)

1 reference

11 May 2018

author

Miloud Kaddar

3

1 reference

11 May 2018

Patrick L F Zuber

1

object named as

Patrick L F Zuber

1 reference

11 May 2018

author name string

Ibrahim El-Ziq

2

1 reference

11 May 2018

Ann E Ottosen

4

1 reference

11 May 2018

Katinka Rosenbaum

5

1 reference

11 May 2018

Meredith Shirey

6

1 reference

11 May 2018

Lidija Kamara

7

1 reference

11 May 2018

Philippe Duclos

8

1 reference

11 May 2018

language of work or name

English

0 references

publication date

24 February 2011

1 reference

11 May 2018

published in

Vaccine

1 reference

11 May 2018

volume

29

1 reference

11 May 2018

issue

17

1 reference

11 May 2018

page(s)

3149-3154

1 reference

11 May 2018

The introduction of new vaccines into developing countries.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Forecasting demand for Hib-containing vaccine in the world's poorest countries: a 4-year prospective experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Introducing GAVI and the Global Fund for Children's Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

A global look at national Immunization Technical Advisory Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

National immunization advisory committees of the World Health Organization's European Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

The role of emerging manufacturers in access to innovative vaccines of public health importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

GAVI enters its second decade with massive funding gap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Are current debt relief initiatives an option for scaling up health financing in beneficiary countries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

Paving the way for the introduction of new vaccines into developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.042

10.1016/J.VACCINE.2011.02.042

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

release_tu3tqncfbvgulbfymfrahmadha

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tu3tqncfbvgulbfymfrahmadha

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 May 2018